Last reviewed: July 9, 2026

Last updated: July 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Ozempic is a branded injectable semaglutide product that delivers glucagon-like peptide-1 (GLP-1) receptor agonist therapy in carefully measured doses. Each pen is pre-filled with a specific milligram amount, and patients typically start at a lower dose before increasing over several weeks. PlexusDx offers compounded semaglutide injections that follow similar dosing principles while providing access without insurance requirements.

Start your GLP-1 program with PlexusDx

One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.

Start your intake →

What Milligram Amounts Come in Ozempic Pens

Ozempic pens contain semaglutide in four standard dose strengths: 0.25 mg, 0.5 mg, 1 mg, and 2.4 mg per injection. Each prefilled pen delivers one fixed dose, so a patient cannot adjust the amount within a single pen. The 0.25 mg and 0.5 mg pens are typically used during the initial four-week period, while higher doses are introduced after tolerance is established.

The 2.4 mg dose represents the maximum dose used in most weight loss protocols and became notably popular after obesity-focused clinical trials demonstrated significant body weight reduction at this level. Patients do not jump directly to 2.4 mg; instead, they follow a stepwise titration schedule designed to minimize gastrointestinal side effects and allow the body to adjust to GLP-1 receptor activation.

Understanding the Dosing Schedule for Semaglutide

The standard semaglutide dosing schedule begins with 0.25 mg once weekly, increasing by 0.25 mg increments each week until reaching a therapeutic dose. Most patients progress to 0.5 mg in week two, 1 mg by week three or four, and continue upward based on individual tolerance and clinical response. This gradual approach reduces nausea and allows appetite suppression mechanisms to activate progressively.

Some patients achieve their weight loss goals at the 1 mg dose and elect to remain there, while others continue the titration toward 2.4 mg for additional metabolic benefit. Your provider will monitor your progress and adjust your target dose based on how well you respond and whether side effects become problematic.

Branded Ozempic vs. Compounded Semaglutide Injections

Ozempic is a brand-name injectable produced by Novo Nordisk, while PlexusDx offers compounded semaglutide injections made at licensed 503A compounding pharmacies. Both deliver the same active pharmaceutical ingredient (semaglutide) and follow comparable dosing protocols, but compounded versions are often more accessible and affordable without insurance.

PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan with no insurance required and no membership fees. The pricing remains flat across all dose levels—your dose may need to go up, but your price won't. This contrasts with some branded or pharmacy-based models that charge higher copays at stronger doses, making treatment planning simpler and more transparent.

How Genetic Testing Helps Personalize Your Semaglutide Dose

Not all patients respond identically to semaglutide at the same dose, because genetic variation in GLP-1 receptor signaling and appetite regulation pathways affects individual outcomes. PlexusDx offers the Precision Peptide Genetic Test, which analyzes genetic variants like GIPR rs1800437 and FTO rs9939609, and MC4R rs17782313 to map 14 metabolic pathways and 49 peptides relevant to weight loss.

This genetic mapping can reveal whether you may be a strong responder, moderate responder, or slower responder to GLP-1 therapy at standard doses. Understanding your peptide pathway genetics helps your provider tailor your dose progression and choose between semaglutide, tirzepatide, or dual-compound protocols for maximum personalized efficacy. The Precision Peptide Genetic Test is available for $298.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What is the highest milligram dose available in Ozempic pens?

The maximum Ozempic dose is 2 mg per weekly injection. This is typically the endpoint of a gradual titration process and is used for patients seeking maximum weight loss and metabolic benefit. Always follow your provider's dosing schedule rather than self-advancing doses.

How many weeks does it take to reach the highest semaglutide dose?

Most patients require 8–12 weeks to progress from the starting 0.25 mg dose to the 2.4 mg dose, increasing by 0.25 mg weekly. Some patients plateau at lower doses like 1 mg or 1.5 mg if they achieve their goals and tolerate that level well. The timeline depends on your individual gastrointestinal response and clinical progress.

Does PlexusDx charge more for higher semaglutide doses?

No. PlexusDx compounded semaglutide injections are priced at $189/mo (or $149/mo on the 6-month plan) flat, regardless of whether you are at 0.25 mg, 1 mg, or 2.4 mg. Your dose may increase during titration, but your monthly cost remains the same—no insurance needed and no membership fees.

Can I stay on a lower semaglutide dose if it's working for me?

Yes. If you achieve your weight loss target and feel good at 0.5 mg, 1 mg, or 1.5 mg, you can maintain that dose indefinitely with your provider's approval. Weight loss plateaus are normal, and dose adjustments should always be made in consultation with your healthcare team, not independently.

How does the Precision Peptide Genetic Test help with semaglutide dosing?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves